ZYMAR® (gatifloxacin ophthalmic solution) solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic Gram-Positive Bacteria:
Aerobic Gram-Negative Bacteria:
* Efficacy for this organism was studied in fewer than 10 infections
DOSAGE AND ADMINISTRATION
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.
Days 3 through 7: Instill one drop up to four times daily while awake.
ZYMAR® (gatifloxacin ophthalmic solution) (gatifloxacin ophthalmic solution) 0.3% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip and a tan, high impact polystyrene (HIPS) cap in the following sizes:
2.5 mL in a 6 mL bottle- NDC 0023-9218-03
5 mL in an 10 mL bottle- NDC 0023-9218-05
Note: Store at 15°-25°C (59°-77°F). Protect from freezing.
Revised August 2004 ©2004 Allergan, Inc. Irvine, CA 92612,
U.S.A. Licensed from: Kyorin Pharmaceuticals Co., Ltd. Marks owned by Allergan,
FDA Rev date: 6/20/2005
Last reviewed on RxList: 8/14/2007
Additional Zymar Information
Zymar - User Reviews
Zymar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.